DE69830154D1 - Pharmazeutische zusammensetzungen - Google Patents

Pharmazeutische zusammensetzungen

Info

Publication number
DE69830154D1
DE69830154D1 DE69830154T DE69830154T DE69830154D1 DE 69830154 D1 DE69830154 D1 DE 69830154D1 DE 69830154 T DE69830154 T DE 69830154T DE 69830154 T DE69830154 T DE 69830154T DE 69830154 D1 DE69830154 D1 DE 69830154D1
Authority
DE
Germany
Prior art keywords
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69830154T
Other languages
English (en)
Other versions
DE69830154T2 (de
Inventor
Thi Nguyen
M Casey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9706295.4A external-priority patent/GB9706295D0/en
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DE69830154D1 publication Critical patent/DE69830154D1/de
Publication of DE69830154T2 publication Critical patent/DE69830154T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • AIDS & HIV (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE69830154T 1997-03-24 1998-03-20 Pharmazeutische zusammensetzungen Expired - Lifetime DE69830154T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4235397P 1997-03-24 1997-03-24
US42353P 1997-03-24
GB9706295 1997-03-26
GBGB9706295.4A GB9706295D0 (en) 1997-03-26 1997-03-26 Lamivudine formulation
PCT/EP1998/001626 WO1998042321A2 (en) 1997-03-24 1998-03-20 Liquid compositions comprising lamivudine

Publications (2)

Publication Number Publication Date
DE69830154D1 true DE69830154D1 (de) 2005-06-16
DE69830154T2 DE69830154T2 (de) 2005-10-13

Family

ID=26311267

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69830154T Expired - Lifetime DE69830154T2 (de) 1997-03-24 1998-03-20 Pharmazeutische zusammensetzungen

Country Status (40)

Country Link
US (1) US6004968A (de)
EP (1) EP0969815B1 (de)
JP (1) JP3264937B2 (de)
KR (1) KR100484695B1 (de)
CN (1) CN1191061C (de)
AP (1) AP1141A (de)
AR (1) AR011697A1 (de)
AT (1) ATE295150T1 (de)
AU (1) AU728461B2 (de)
BG (1) BG64690B1 (de)
BR (1) BR9808060B1 (de)
CA (1) CA2286126C (de)
CO (1) CO4980849A1 (de)
CY (1) CY2569B1 (de)
CZ (1) CZ298008B6 (de)
DE (1) DE69830154T2 (de)
EA (1) EA001990B1 (de)
EE (1) EE03996B1 (de)
ES (1) ES2239802T3 (de)
HK (1) HK1022853A1 (de)
HN (1) HN1998000045A (de)
HR (1) HRP980154B1 (de)
HU (1) HU225600B1 (de)
ID (1) ID29294A (de)
IL (1) IL131917A0 (de)
IS (1) IS2515B (de)
MY (1) MY116242A (de)
NO (1) NO326719B1 (de)
NZ (1) NZ337798A (de)
PA (1) PA8449301A1 (de)
PE (1) PE61699A1 (de)
PL (1) PL190505B1 (de)
PT (1) PT969815E (de)
RS (1) RS49772B (de)
SI (1) SI0969815T1 (de)
SK (1) SK283417B6 (de)
SV (1) SV1998000040A (de)
TW (1) TW536403B (de)
UY (1) UY24930A1 (de)
WO (1) WO1998042321A2 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1228026A (zh) 1996-06-25 1999-09-08 葛兰素集团有限公司 用于治疗hiv感染的含有vx478、叠氮胸苷、ftc和/或3tc的复方制剂
US6018044A (en) * 1998-01-02 2000-01-25 Roche Vitamins Inc. Light screening compositions
US6432966B2 (en) * 1999-10-29 2002-08-13 Smithkline Beecham Corporation Antiviral combinations
JP2003039582A (ja) * 2001-07-19 2003-02-13 Three M Innovative Properties Co 湿潤防滑性シート及び湿潤防滑構造体
US6855346B2 (en) * 2001-10-05 2005-02-15 Tzu-Sheng Wu Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
TWI275392B (en) * 2002-04-08 2007-03-11 Bristol Myers Squibb Co Low dose liquid entecavir formulations and use
CN100353997C (zh) * 2003-02-28 2007-12-12 中外制药株式会社 稳定的含蛋白质的制剂
US20040228804A1 (en) * 2003-05-16 2004-11-18 Jones Alonzo H. Nasal administration of xylitol to a non-human mammal
PE20060484A1 (es) * 2004-07-14 2006-07-06 Ucb Farchim Sa Preparaciones farmaceuticas liquidas que comprenden un compuesto de benzhidril piperizina
CN100427082C (zh) * 2005-08-02 2008-10-22 盛华（广州）医药科技有限公司 羟基苯甲酸酯及其类似物在制备预防和治疗病毒性感染药物中的应用
GB2470494B (en) * 2008-01-17 2012-08-08 Univ Holy Ghost Duquesne Antiretroviral drug formulations for treatment of children exposed to HIV/AIDS
RU2587782C1 (ru) * 2015-01-19 2016-06-20 Общество с ограниченной ответственностью "Трейдсервис" Стабильная фармацевтическая композиция ламивудина

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5047407A (en) * 1989-02-08 1991-09-10 Iaf Biochem International, Inc. 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties
SK279262B6 (sk) * 1991-05-16 1998-08-05 Glaxo Group Limited Protivírusová zmes, farmaceutický prostriedok s je
GB9111902D0 (en) * 1991-06-03 1991-07-24 Glaxo Group Ltd Chemical compounds
GB9503850D0 (en) * 1995-02-25 1995-04-19 Glaxo Group Ltd Medicaments
MY115461A (en) * 1995-03-30 2003-06-30 Wellcome Found Synergistic combinations of zidovudine, 1592u89 and 3tc
GB9605293D0 (en) * 1996-03-13 1996-05-15 Glaxo Group Ltd Medicaments

Also Published As

Publication number Publication date
BR9808060B1 (pt) 2009-05-05
EP0969815B1 (de) 2005-05-11
PA8449301A1 (es) 2000-05-24
SV1998000040A (es) 1999-03-16
PL336038A1 (en) 2000-06-05
WO1998042321A2 (en) 1998-10-01
MY116242A (en) 2003-12-31
BG103818A (en) 2000-06-30
PE61699A1 (es) 1999-07-08
DE69830154T2 (de) 2005-10-13
CN1255849A (zh) 2000-06-07
CN1191061C (zh) 2005-03-02
KR100484695B1 (ko) 2005-04-22
HRP980154B1 (en) 2002-06-30
JP3264937B2 (ja) 2002-03-11
PT969815E (pt) 2005-07-29
TW536403B (en) 2003-06-11
EE9900440A (et) 2000-04-17
BR9808060A (pt) 2000-03-08
CA2286126A1 (en) 1998-10-01
HUP0002982A3 (en) 2001-12-28
ATE295150T1 (de) 2005-05-15
EE03996B1 (et) 2003-04-15
IS2515B (is) 2009-06-15
ID29294A (id) 2001-08-16
AP1141A (en) 2003-01-29
IL131917A0 (en) 2001-03-19
NO994619D0 (no) 1999-09-23
EA001990B1 (ru) 2001-10-22
NZ337798A (en) 2001-03-30
CZ298008B6 (cs) 2007-05-23
SI0969815T1 (de) 2005-08-31
AU7208498A (en) 1998-10-20
CA2286126C (en) 2003-08-12
IL131917A (en) 2001-01-11
WO1998042321A3 (en) 1999-01-07
PL190505B1 (pl) 2005-12-30
US6004968A (en) 1999-12-21
HN1998000045A (es) 1999-03-19
EP0969815A2 (de) 2000-01-12
EA199900757A1 (ru) 2000-08-28
BG64690B1 (bg) 2005-12-30
JP2001501974A (ja) 2001-02-13
CZ340399A3 (cs) 2000-04-12
AP9901657A0 (en) 1999-09-30
KR20010005624A (ko) 2001-01-15
HU225600B1 (en) 2007-05-02
HRP980154A2 (en) 1998-12-31
IS5184A (is) 1999-09-17
NO326719B1 (no) 2009-02-02
AU728461B2 (en) 2001-01-11
RS49772B (sr) 2008-06-05
NO994619L (no) 1999-11-23
CY2569B1 (en) 2008-07-02
CO4980849A1 (es) 2000-11-27
HK1022853A1 (en) 2000-08-25
HUP0002982A2 (hu) 2001-01-29
ES2239802T3 (es) 2005-10-01
YU47799A (sh) 2002-06-19
AR011697A1 (es) 2000-08-30
UY24930A1 (es) 2000-10-31
SK283417B6 (sk) 2003-07-01
SK129999A3 (en) 2000-07-11

Similar Documents

Publication Publication Date Title
DE69924999D1 (de) Lipasehemmer enthaltende pharmazeutische zusammensetzungen
ID24654A (id) Formulasi farmasi omeprazola
DE69807420T2 (de) Pharmazeutische aerosolzusammensetzung
NO992339L (no) Farmasöytiske formuleringer
ID27415A (id) Komposisi farmaseutik
ID18352A (id) Komposisi-komposisi farmasi
ID29262A (id) Komposisi farmasi
DE59915033D1 (de) Pharmazeutische Zubereitung
ID27201A (id) Komposisi farmasi
DE59801987D1 (de) Pharmazeutische zusammensetzung enthaltend peptichemio
EE9900545A (et) Farmatseutiline kompositsioon
DE69830154D1 (de) Pharmazeutische zusammensetzungen
DE69614407D1 (de) Pharmazeutische zusammensetzungen
ID30032A (id) Formulasi farmasi
EE200000330A (et) Farmatseutilised kompositsioonid
PT941100E (pt) Composicoes farmaceuticas
DE69530605D1 (de) Lycopen enthaltende pharmazeutische zusammensetzungen
ID26215A (id) Komposisi farmasi
NO994436D0 (no) Farmasöytiske sammensetninger
ATA77096A (de) Pharmazeutische präparation
BR1100755A (pt) composição farmacêutica
FI3862U1 (fi) Geelimuotoinen farmaseuttinen valmiste
SE9803952D0 (sv) Pharmaceutical formulation
ID21180A (id) Senyawa-senyawa farmasi
BR1101151A (pt) Compostos e composição farmacêutica

Legal Events

Date Code Title Description
8364 No opposition during term of opposition